Choline salicylate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H5O3.C5H14NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KD510K1IQW, chemically known as 2-hydroxy-n,n,n-trimethylethanaminium salt with 2-hydroxybenzoic acid (1:1) but generally known as choline salicylate, which bears US NIH Compound Identifier 16213. European Medicines Agency schedules Choline salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06219MIG. The term CHOLINE SALICYLATE is an International Non-Proprietary Name. World Health Organization schedules choline salicylate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule choline salicylate under HS 29231000 and SITC 51481. As of Q4 2014, CHOLINE SALICYLATE remains the US FDA Preferred Term for this commodity. Choline salicylate bears US NLM identifiers UMLS ID C0055573 and NCI Concept Code C76798. SMILES: OCC[N](C)(C)C.OC1C(CCCC1)C(=O)O.